Physostigmine temporarily and dramatically reversing acute mania.
Khouzam
H R
HR
Kissmeyer
P M
PM
D000978:Antiparkinson Agents / Q000008:administration & dosage / Q000506:poisoning*; D001590:Benztropine / Q000008:administration & dosage / Q000506:poisoning; D001714:Bipolar Disorder / Q000139:chemically induced / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D062787:Drug Overdose / Q000188:drug therapy / Q000523:psychology; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010277:Parasympathomimetics / Q000627:therapeutic use*; D010830:Physostigmine / Q000627:therapeutic use*; D014728:Veterans / Q000523:psychology*
D000978:Antiparkinson Agents; D010277:Parasympathomimetics; D001590:Benztropine; D010830:Physostigmine